MetaCap

ResMed Statistics

NYSE: RMDHealth CareMedical/Dental InstrumentsUSD

225.98+5.29 (+2.40%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

ResMed by the numbers

ResMed has a market capitalization of $31.78 billion based on 140.64M shares outstanding. Its trailing P/E ratio is 21.2, below the 6-company peer median of 44.4, and its forward P/E is 17.1. The stock trades 0.8% above its 50-day average and 0.2% above its 200-day average.

Average daily trading volume is 1.34M shares, or about $303.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RMD valuation vs. peer median

RMD compared with the median of 8 peer companies
MetricRMDPeer medianDifference
Market cap$31.78B$20.21B+57%
P/E (TTM)21.244.4-52%
Forward P/E17.124.7-31%
Dividend yield1.06%0.83%+27%
Avg. volume1.34M1.40M-4%

Peer median across 8 companies: DXCM, WST, MDLN, SOLV, BDX, PEN, BAX, GKOS.

Valuation

Market cap
$31.78B
Price / sales (latest FY)
5.62
EPS (TTM)
$10.68

Price and trading

Previous close
220.69
Open
222.27
Day range
221.83 – 228.75
52-week range
180.27 – 284.05
52-week change
-20.23%
Beta
—
Volume
1.13M

Dividends and events

Annual dividend
$2.40
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
31.78B
Pe
21.16
Forward Pe
17.08
Eps
10.68
Dividend Yield
117.00%
Dividend Rate
2.40
Week52 High
284.05
Week52 Low
180.27
Avg Volume
1.34M
Shares Outstanding
140.64M
Ma50
224.17
Ma200
225.46
Earnings Date
Oct 29, 2026
Pct From52w High
-20.44%
Pct From52w Low
25.36%

Related